HIMS Hims & Hers Health, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Hims & Hers Health, Inc. (HIMS) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 23, 2026, a 10-Q quarterly report filed on November 3, 2025, an 8-K current report filed on March 11, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Hims & Hers Health, Inc. (HIMS) (SEC CIK 1773751), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Consumer-first digital health platform offering telehealth consultations, personalized prescription and non-prescription products, and laboratory testing
- • New 2025 offerings: Testosterone, menopause, perimenopause support, and comprehensive laboratory testing for early health risk identification
Risk Factors
- • Cybersecurity risks reviewed quarterly by Audit Committee with escalation to CTO and executive leadership
- • Head of Information Security with 20 years experience, certified CISSP, CCSP, CRISC, CCISO, reporting to CTO
Management Discussion & Analysis
- • Revenue $2.35B in 2025, up 59% YoY from $1.48B in 2024, driven by U.S. Revenue growth $2.21B (+53%) and Rest of World Revenue $134M (+399%)
- • Online Revenue $2.31B in 2025, up 61% YoY from $1.44B; Wholesale Revenue $36.2M down 6% YoY from $38.6M
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Risk Factors
- • New risk: Constraints on compounded semaglutide supply post FDA shortage resolution May 2025 impacting access and pricing, triggered by evolving GLP-1 regulatory landscape
- • Most updated risk: Rapid revenue growth to $1.48B in 2024 with headcount up to 1,637 increases operational strain and requires improved management controls
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings results announced Feb 23, 2026
- • Full financial details contained in Exhibit 99.1 (press release) and Exhibit 99.2 (shareholder letter)
Annual Reports Archive10-K
AI-powered analysis of Hims & Hers Health, Inc. (HIMS) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Hims & Hers Health, Inc. (HIMS) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Hims & Hers Health, Inc. (HIMS) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | — | $872.0M | $1.5B | $2.3B |
| Gross Profit | — | $714.9M | $1.2B | $1.7B |
| Operating Income | — | -$29.5M | $61.9M | $105.6M |
| Net Income | — | -$23.5M | $126.0M | $128.4M |
| Gross Margin | — | 82.0% | 79.5% | 73.8% |
| Op. Margin | — | -3.4% | 4.2% | 4.5% |
| Net Margin | — | -2.7% | 8.5% | 5.5% |
| Balance Sheet | ||||
| Total Assets | $366.3M | $441.2M | $707.5M | $2.2B |
| Equity | $311.7M | $344.0M | $476.7M | $540.9M |
| ROE | — | -6.8% | 26.4% | 23.7% |
Source: XBRL financial data from Hims & Hers Health, Inc. (HIMS) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 11, 2026 | — | — | — |
8-K | Feb 23, 2026 | — | Analysis | — |
10-K | Feb 23, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 19, 2026 | — | — | |
10-Q | Nov 3, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 4, 2025 | Jun 30, 2025 | — | |
10-Q | May 5, 2025 | Mar 31, 2025 | — | |
10-K | Feb 24, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 4, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 5, 2024 | Jun 30, 2024 | — | |
10-Q | May 6, 2024 | Mar 31, 2024 | — | |
10-K | Feb 26, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 6, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 7, 2023 | Jun 30, 2023 | — | |
10-Q | May 8, 2023 | Mar 31, 2023 | — | |
10-K | Feb 27, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 8, 2022 | Jun 30, 2022 | — | |
10-Q | May 9, 2022 | Mar 31, 2022 | — | |
10-K | Feb 24, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 10, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 11, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest HIMS SEC filings in 2026?
Hims & Hers Health, Inc. (HIMS) has filed a 10-K annual report on February 23, 2026, a 10-Q quarterly report on November 3, 2025, an 8-K current report on March 11, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did HIMS file its most recent 10-K annual report?
Hims & Hers Health, Inc. (HIMS) filed its most recent 10-K annual report on February 23, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view HIMS 10-Q quarterly reports?
Hims & Hers Health, Inc. (HIMS)'s most recent 10-Q quarterly report was filed on November 3, 2025. SignalX displays every HIMS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has HIMS filed recently?
Hims & Hers Health, Inc. (HIMS)'s most recent 8-K was filed on March 11, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find HIMS insider trading activity (Form 4)?
SignalX aggregates every HIMS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does HIMS file with the SEC?
Hims & Hers Health, Inc. (HIMS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new HIMS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Hims & Hers Health, Inc. (HIMS).
What is HIMS's SEC CIK number?
Hims & Hers Health, Inc. (HIMS)'s SEC CIK (Central Index Key) number is 1773751. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1773751 to look up all HIMS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find HIMS return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Hims & Hers Health, Inc. (HIMS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Hims & Hers Health, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 22+ filings.